Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AstraZeneca PLC (LSE: AZN) Latest News

    Syringe and vial on blue background
    Investing Articles

    AstraZeneca shares: Hargreaves Lansdown investors are buying. Should I buy too?

    | Roland Head

    AstraZeneca shares have fallen by more than 25% since last summer. Roland Head has been taking a fresh look. Is…

    Read more »

    Investing Articles

    AstraZeneca’s Covid-19 vaccine approved! Here’s what I’d do now

    | Zaven Boyrazian, MSc

    Approval for AstraZeneca’s vaccine brings the UK a step closer to winning the fight against Covid-19. But is there a…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Will the AstraZeneca share price be the largest FTSE 100 riser in 2021?

    | Stuart Blair

    The AstraZeneca share price has performed well under Pascal Soriot. After its acquisition of Alexion, will it rise further in…

    Read more »

    Investing Articles

    The 2 UK shares I would buy before the year ends

    | Karl Loomes

    As 2020 draws to a close, here are the top two UK shares I would buy before the New Year.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The AstraZeneca share price outperformed the FTSE 100 in 2020

    | Alan Oscroft

    Covid-19 gave the AstraZeneca share price an early boost. That fell away, but iits shares look set to end 2020…

    Read more »

    Union Jack flag in a castle shaped sandcastle on a beautiful beach in brilliant sunshine
    Investing Articles

    I’d buy GlaxoSmithKline and AstraZeneca given this huge AI breakthrough

    | Jay Yao

    Despite the tepid market reaction, Jay Yao writes why he thinks the recent AI protein folding news is bullish for…

    Read more »

    Newspaper and direction sign with investment options
    Investing Articles

    Here’s what I think the AstraZeneca vaccine means for the dividend

    | Jay Yao

    Jay Yao writes how he thinks AstraZeneca’s Covid-19 vaccine candidate could affect the company’s dividend payments in the coming years.

    Read more »

    Investing Articles

    The top 2 UK shares I would buy today

    | Karl Loomes

    As Christmas approaches, here are my top two UK shares I would pick up today.

    Read more »

    Newspaper and direction sign with investment options
    Investing Articles

    What I think AstraZeneca’s purchase of Alexion means for the dividend

    | Jay Yao

    Jay Yao writes how he thinks AstraZeneca’s recent agreement to buy Alexion Pharmaceuticals affects the company’s dividend.

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Can the AstraZeneca share price touch £100? 

    | Manika Premsingh

    The AstraZeneca share price has had a standout 2020. But is the best behind it or is there more to…

    Read more »

    Investing Articles

    Why FTSE 100 firm AstraZeneca’s shares fell and Codemasters’ stock soared 20% today

    | Kirsteen Mackay

    FTSE 100 pharma giant AstraZeneca is seeing its share price fall today, but UK gaming stock Codemasters is flying on…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    Will the AstraZeneca share price go back to £10 after the $39bn Alexion deal?

    | Roland Head

    The AstraZeneca share price is down nearly 25% from July's record highs. But Roland Head reckons today's acquisition bid could…

    Read more »